Collectively, these findings suggest that metformin alleviates inflammation and bone resorption in periodontitis by inhibiting the interaction between CD81+ fibroblasts and neutrophils, which provides a novel therapeutic strategy for periodontitis. This evidence concerns the gene CD81 and periodontitis.